Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ... British journal of cancer 85 (5), 692-696, 2001 | 1081 | 2001 |
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation MK Gjertsen, J Breivik, I Saeterdal, E Thorsby, G Gaudernack, A Bakka, ... The Lancet 346 (8987), 1399-1400, 1995 | 244 | 1995 |
Different genetic pathways to proximal and distal colorectal cancer influenced by sex‐related factors J Breivik, RA Lothe, GI Meling, TO Rognum, AL Børresen‐Dale, ... International journal of cancer 74 (6), 664-669, 1997 | 238 | 1997 |
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location J Breivik, GI Meling, A Spurkland, TO Rognum, G Gaudernack British journal of cancer 69 (2), 367-371, 1994 | 190 | 1994 |
Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis J Breivik, G Gaudernack Seminars in cancer biology 9 (4), 245-254, 1999 | 172 | 1999 |
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study MK Gjertsen, A Bakka, J Breivik, I Saeterdal, T Gedde‐Dahl III, KT Stokke, ... International journal of cancer 65 (4), 450-453, 1996 | 138 | 1996 |
Evaluation of the medical student research programme in Norwegian medical schools. A survey of students and supervisors S Hunskaar, J Breivik, M Siebke, K Tømmerås, K Figenschau, JB Hansen BMC medical education 9, 1-8, 2009 | 134 | 2009 |
The evolutionary origin of genetic instability in cancer development J Breivik Seminars in cancer biology 15 (1), 51-60, 2005 | 123 | 2005 |
p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation … B Fossum, T Gedde‐Dahl III, J Breivik, JA Eriksen, A Spurkland, ... International journal of cancer 56 (1), 40-45, 1994 | 114 | 1994 |
K-ras Mutations and Prognosis in Large-Bowel Carcinomas SN Andersen, T Løvig, J Breivik, E Lund, G Gaudernack, GI Meling, ... Scandinavian journal of gastroenterology 32 (1), 62-69, 1997 | 76 | 1997 |
Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer J Breivik, G Gaudernack Advances in cancer research 76, 187-213, 1999 | 65 | 1999 |
Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development J Breivik Proceedings of the National Academy of Sciences 98 (10), 5379-5381, 2001 | 57 | 2001 |
Self-organization of template-replicating polymers and the spontaneous rise of genetic information J Breivik Entropy 3 (4), 273-279, 2001 | 56 | 2001 |
Frame that gene: A tool for analysing and classifying the communication of genetics to the public R Carver, R Waldahl, J Breivik EMBO reports 9 (10), 943-947, 2008 | 43 | 2008 |
A K‐ras 13GLY → ASP mutation is recognized by HLA‐DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers … B Fossum, J Breivik, GI Meling, TGD Iii, T Hansen, I Knutsen, TO Rognum, ... International journal of cancer 58 (4), 506-511, 1994 | 43 | 1994 |
K-ras mutations and HLA-DR expression in large bowel adenomas S Norheim Andersen, J Breivik, T Løvig, GI Meling, G Gaudernack, ... British journal of cancer 74 (1), 99-108, 1996 | 41 | 1996 |
Can IVF influence human evolution? HI Hanevik, DO Hessen, A Sunde, J Breivik Human Reproduction 31 (7), 1397-1402, 2016 | 39 | 2016 |
Resolving the evolutionary paradox of genetic instability: a cost–benefit analysis of DNA repair in changing environments J Breivik, G Gaudernack FEBS letters 563 (1-3), 7-12, 2004 | 39 | 2004 |
Isolation of nucleic acid J Breivik, G Gaudernack, A Spurkland US Patent 6,090,935, 2000 | 38 | 2000 |
Quantitative frame analysis of how the gene concept is presented in tabloid and elite newspapers RB Carver, EA Rødland, J Breivik Science Communication 35 (4), 449-475, 2013 | 31 | 2013 |